An AI-based EGFR biomarker tool could preclude the need for a rapid PCR test in nearly half of advanced lung adenocarcinoma cases, a study has suggested.

In a candid interview with CURE, Terry Gillespie reflects on how her definition of survivorship has evolved from her lung ...

Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...

DCIS is a non-invasive or pre-invasive breast cancer, meaning the cancer cells are confined to the milk ducts and haven’t ...

I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...

Lung cancer surgery is the primary treatment for lung cancer, when possible. Learn about the multiple types of lung cancer surgery, procedures, and associated risks.

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

McDonald discusses her groundbreaking path in interventional pulmonology, overcoming barriers with early lung cancer ...

The selection of a first-line treatment for patients with advanced EGFR -positive non-small cell lung cancer (NSCLC) has ...

A research team led by Prof. LI Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, has developed a new model that can accurately predict lung motion caused by ...

A promising clinical trial shows that a combination of paxalisib, pembrolizumab, and chemotherapy significantly reduces circulating tumor cells in metastatic triple-negative breast cancer.

The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs ...